Antigen Titers in Cryptococcal Meningitis: What Determines How Fast They Fall?

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Neurology

Background:

• Cryptococcal meningitis is a serious infection, particularly in immunocompromised individuals.
• Long-term follow-up of survivors is crucial to understand disease persistence and potential complications.
• Detection of cryptococcal antigen beyond clinical resolution is not well-characterized.

Purpose of the Study:

• To investigate the duration and kinetics of cryptococcal antigen detection in serum and cerebrospinal fluid (CSF) in patients who survived cryptococcal meningitis.
• To identify factors influencing the rate of antigen titer decline.

Main Methods:

• Prospective follow-up study of patients recovering from cryptococcal meningitis.
• Serial measurement of cryptococcal antigen titers in serum and CSF.
• Analysis of antigen titer decline rates and correlation with species and treatment interventions.

Main Results:

• Cryptococcal antigen was detectable for over a year in 86% of serum samples and 67% of CSF samples, long after culture conversion.
• Antigen titer decline was slower in serum than in CSF.
• Clearance was significantly slower in patients infected with Cryptococcus gattii compared to Cryptococcus neoformans.
• Patients with ventriculoperitoneal shunts exhibited slower antigen titer decline in both serum and CSF.

Conclusions:

• Cryptococcal antigen can remain detectable for extended periods post-treatment, irrespective of clinical recovery.
• The rate of antigen clearance is influenced by the infecting Cryptococcus species and the presence of a ventriculoperitoneal shunt.
• These findings highlight the complex dynamics of cryptococcal antigen persistence and underscore the need for further research into their clinical significance.